{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:13:37Z","timestamp":1789719217712,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1124\/jpet.107.127480","type":"journal-article","created":{"date-parts":[[2007,9,29]],"date-time":"2007-09-29T01:09:17Z","timestamp":1191028157000},"page":"234-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["The A3 Adenosine Receptor Agonist CP-532,903 [N6-(2,5-Dichlorobenzyl)-3\u2032-aminoadenosine-5\u2032-N-methylcarboxamide] Protects against Myocardial Ischemia\/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium Channel"],"prefix":"10.1016","volume":"324","author":[{"given":"Tina C.","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Dong","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Tampo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Mio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin W.","family":"Bienengraeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Ross","family":"Tracey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garrett J.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Meng","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Auchampach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.107.127480_bib1","doi-asserted-by":"crossref","unstructured":"Alekseev AE, Hodgson DM, Karger AB, Park S, Zingman LV, and Terzic A (2005) ATP-sensitive K+ channel channel\/enzyme multimer: metabolic gating in the heart. J Mol Cell Cardiol 38: 895\u2013905.","DOI":"10.1016\/j.yjmcc.2005.02.022"},{"key":"10.1124\/jpet.107.127480_bib2","doi-asserted-by":"crossref","unstructured":"Auchampach JA, Ge ZD, Wan TC, Moore J, and Gross GJ (2003) A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol 285: H607\u2013H613.","DOI":"10.1152\/ajpheart.01001.2002"},{"key":"10.1124\/jpet.107.127480_bib3","doi-asserted-by":"crossref","unstructured":"Auchampach JA, Jin X, Wan TC, Caughey GH, and Linden J (1997a) Canine mast cell adenosine receptors: cloning and expression of the A3 receptor and evidence that degranulation is mediated by the A2B receptor. Mol Pharmacol 52: 846\u2013860.","DOI":"10.1124\/mol.52.5.846"},{"key":"10.1124\/jpet.107.127480_bib4","doi-asserted-by":"crossref","unstructured":"Auchampach JA, Rizvi A, Qiu Y, Tang XL, Maldonado C, Teschner S, and Bolli R (1997b) Selective activation of A3 adenosine receptors with N6-(3-iodobenzyl)adenosine-5\u2032-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80: 800\u2013809.","DOI":"10.1161\/01.RES.80.6.800"},{"key":"10.1124\/jpet.107.127480_bib5","doi-asserted-by":"crossref","unstructured":"Black RG Jr, Guo Y, Ge ZD, Murphree SS, Prabhu SD, Jones WK, Bolli R, and Auchampach JA (2002) Gene dosage-dependent effects of cardiac-specific overexpression of the A3 adenosine receptor. Circ Res 91: 165\u2013172.","DOI":"10.1161\/01.RES.0000028007.91385.EE"},{"key":"10.1124\/jpet.107.127480_bib6","doi-asserted-by":"crossref","unstructured":"DeNinno MP, Masamune H, Chenard LK, DiRico KJ, Eller C, Etienne JB, Tickner JE, Kennedy SP, Knight DR, Kong J, et al. (2003) 3\u2032-Aminoadenosine-5\u2032-uronamides: discovery of the first highly selective agonist at the human adenosine A3 receptor. J Med Chem 46: 353\u2013355.","DOI":"10.1021\/jm0255724"},{"key":"10.1124\/jpet.107.127480_bib7","doi-asserted-by":"crossref","unstructured":"DeNinno MP, Masamune H, Chenard LK, DiRico KJ, Eller C, Etienne JB, Tickner JE, Kennedy SP, Knight DR, Kong J, et al. (2006) The synthesis of highly potent, selective, and water-soluble agonists at the human adenosine A3 receptor. Bioorg Med Chem Lett 16: 2525\u20132527.","DOI":"10.1016\/j.bmcl.2006.01.088"},{"key":"10.1124\/jpet.107.127480_bib8","doi-asserted-by":"crossref","unstructured":"Gallo-Rodriguez C, Ji XD, Melman N, Siegman BD, Sanders LH, Orlina J, Fischer B, Pu Q, Olah ME, van Galen PJ, et al. (1994) Structure-activity relationships of N6-benzyladenosine-5\u2032-uronamides as A3-selective adenosine agonists. J Med Chem 37: 636\u2013646.","DOI":"10.1021\/jm00031a014"},{"key":"10.1124\/jpet.107.127480_bib9","doi-asserted-by":"crossref","unstructured":"Ge ZD, Peart JN, Kreckler LM, Wan TC, Jacobson MA, Gross GJ, and Auchampach JA (2006) Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5\u2032-N-methylcarboxamide] reduces ischemia\/reperfusion injury in mice by activating the A3 adenosine receptor. J Pharmacol Exp Ther 319: 1200\u20131210.","DOI":"10.1124\/jpet.106.111351"},{"key":"10.1124\/jpet.107.127480_bib10","unstructured":"Ge ZD, Wan TC, and Auchampach JA (2004) The A3 adenosine receptor agonist Cl-IB-MECA reduces myocardial infarct size in mice when administered during reperfusion: mechanistic studies with A3AR gene `knock-out\u2019 and bone marrow chimeric mice. Circulation 110: III-29."},{"key":"10.1124\/jpet.107.127480_bib11","doi-asserted-by":"crossref","unstructured":"Hanley PJ and Daut J (2005) KATP channels and preconditioning: a re-examination of the role of mitochondrial KATP channels and an overview of alternative mechanisms. J Mol Cell Cardiol 39: 17\u201350.","DOI":"10.1016\/j.yjmcc.2005.04.002"},{"key":"10.1124\/jpet.107.127480_bib12","doi-asserted-by":"crossref","unstructured":"Hannon JP, Pfannkuche HJ, and Fozard JR (1995) A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br J Pharmacol 115: 945\u2013952.","DOI":"10.1111\/j.1476-5381.1995.tb15902.x"},{"key":"10.1124\/jpet.107.127480_bib13","doi-asserted-by":"crossref","unstructured":"Hasko G and Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33\u201339.","DOI":"10.1016\/j.it.2003.11.003"},{"key":"10.1124\/jpet.107.127480_bib14","doi-asserted-by":"crossref","unstructured":"Hill RJ, Oleynek JJ, Hoth CF, Kiron MA, Weng W, Wester RT, Tracey WR, Knight DR, Buchholz RA, and Kennedy SP (1997) Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. J Pharmacol Exp Ther 280: 122\u2013128.","DOI":"10.1016\/S0022-3565(24)36375-X"},{"key":"10.1124\/jpet.107.127480_bib15","doi-asserted-by":"crossref","unstructured":"Inagaki N, Gonoi T, Clement JP, Wang CZ, Aguilar-Bryan L, Bryan J, and Seino S (1996) A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16: 1011\u20131017.","DOI":"10.1016\/S0896-6273(00)80124-5"},{"key":"10.1124\/jpet.107.127480_bib16","doi-asserted-by":"crossref","unstructured":"Inagaki N, Gonoi T, Clement JPt, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, and Bryan J (1995) Reconstitution of IKATP: an inward rectifier subunit plus the sulfonylurea receptor. Science 270: 1166\u20131170.","DOI":"10.1126\/science.270.5239.1166"},{"key":"10.1124\/jpet.107.127480_bib17","unstructured":"Institute of Laboratory Animal Resources (1996) Guide for the Care and Use of Laboratory Animals 7th ed. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, Washington DC."},{"key":"10.1124\/jpet.107.127480_bib18","doi-asserted-by":"crossref","unstructured":"Jordan JE, Thourani VH, Auchampach JA, Robinson JA, Wang NP, and Vinten-Johansen J (1999) A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am J Physiol Heart Circ Physiol 277: H1895\u2013H1905.","DOI":"10.1152\/ajpheart.1999.277.5.H1895"},{"key":"10.1124\/jpet.107.127480_bib19","doi-asserted-by":"crossref","unstructured":"Kane GC, Liu XK, Yamada S, Olson TM, and Terzic A (2005) Cardiac KATP channels in health and disease. J Mol Cell Cardiol 38: 937\u2013943.","DOI":"10.1016\/j.yjmcc.2005.02.026"},{"key":"10.1124\/jpet.107.127480_bib20","doi-asserted-by":"crossref","unstructured":"Kim HO, Ji XD, Siddiqi SM, Olah ME, Stiles GL, and Jacobson KA (1994) 2-Substitution of N6-benzyladenosine-5\u2032-uronamides enhances selectivity for A3 adenosine receptors. J Med Chem 37: 3614\u20133621.","DOI":"10.1021\/jm00047a018"},{"key":"10.1124\/jpet.107.127480_bib21","doi-asserted-by":"crossref","unstructured":"Kreckler LM, Wan TC, Ge ZD, and Auchampach JA (2006) Adenosine inhibits tumor necrosis factor-alpha release from mouse peritoneal macrophages via A2A and A2B but not the A3 adenosine receptor. J Pharmacol Exp Ther 317: 172\u2013180.","DOI":"10.1124\/jpet.105.096016"},{"key":"10.1124\/jpet.107.127480_bib22","doi-asserted-by":"crossref","unstructured":"Ljubkovic M, Mio Y, Marinovic J, Stadnicka A, Warltier DC, Bosnjak ZJ, and Bienengraeber M (2007) Isoflurane preconditioning uncouples mitochondria and protects against hypoxia-reoxygenation. Am J Physiol Cell Physiol 292: C1583\u2013C1590.","DOI":"10.1152\/ajpcell.00221.2006"},{"key":"10.1124\/jpet.107.127480_bib23","doi-asserted-by":"crossref","unstructured":"Miki T, Nagashima K, Tashiro F, Kotake K, Yoshitomi H, Tamamoto A, Gonoi T, Iwanaga T, Miyazaki J, and Seino S (1998) Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. Proc Natl Acad Sci U S A 95: 10402\u201310406.","DOI":"10.1073\/pnas.95.18.10402"},{"key":"10.1124\/jpet.107.127480_bib24","doi-asserted-by":"crossref","unstructured":"Murphree LJ, Marshall MA, Rieger JM, MacDonald TL, and Linden J (2002) Human A2A adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing G\u03b24. Mol Pharmacol 61: 455\u2013462.","DOI":"10.1124\/mol.61.2.455"},{"key":"10.1124\/jpet.107.127480_bib25","doi-asserted-by":"crossref","unstructured":"Seino S (1999) ATP-sensitive potassium channels: a model of heteromultimeric potassium channel\/receptor assemblies. Annu Rev Physiol 61: 337\u2013362.","DOI":"10.1146\/annurev.physiol.61.1.337"},{"key":"10.1124\/jpet.107.127480_bib26","doi-asserted-by":"crossref","unstructured":"Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, and Nakaya H (2002) Role of sarcolemmal KATP channels in cardioprotection against ischemia\/reperfusion injury in mice. J Clin Invest 109: 509\u2013516.","DOI":"10.1172\/JCI200214270"},{"key":"10.1124\/jpet.107.127480_bib27","doi-asserted-by":"crossref","unstructured":"Takano H, Bolli R, Black RG Jr., Kodani E, Tang XL, Yang Z, Bhattacharya S, and Auchampach JA (2001) A1 or A3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88: 520\u2013528.","DOI":"10.1161\/01.RES.88.5.520"},{"key":"10.1124\/jpet.107.127480_bib28","doi-asserted-by":"crossref","unstructured":"Thourani VH, Nakamura M, Ronson RS, Jordan JE, Zhao ZQ, Levy JH, Szlam F, Guyton RA, and Vinten-Johansen J (1999) Adenosine A3-receptor stimulation attenuates postischemic dysfunction through KATP channels. Am J Physiol Heart Circ Physiol 277: H228\u2013H235.","DOI":"10.1152\/ajpheart.1999.277.1.H228"},{"key":"10.1124\/jpet.107.127480_bib29","doi-asserted-by":"crossref","unstructured":"Tracey WR, Magee W, Masamune H, Kennedy SP, Knight DR, Buchholz RA, and Hill RJ (1997) Selective adenosine A3 receptor stimulation reduces ischemic myocardial injury in the rabbit heart. Cardiovasc Res 33: 410\u2013415.","DOI":"10.1016\/S0008-6363(96)00240-4"},{"key":"10.1124\/jpet.107.127480_bib30","doi-asserted-by":"crossref","unstructured":"Tracey WR, Magee W, Masamune H, Oleynek JJ, and Hill RJ (1998) Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5\u2032-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation. Cardiovasc Res 40: 138\u2013145.","DOI":"10.1016\/S0008-6363(98)00112-6"},{"key":"10.1124\/jpet.107.127480_bib31","doi-asserted-by":"crossref","unstructured":"Tracey WR, Magee WP, Oleynek JJ, Hill RJ, Smith AH, Flynn DM, and Knight DR (2003) Novel N6-substituted adenosine 5\u2032-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury. Am J Physiol Heart Circ Physiol 285: H2780\u2013H2787.","DOI":"10.1152\/ajpheart.00411.2003"},{"key":"10.1124\/jpet.107.127480_bib32","doi-asserted-by":"crossref","unstructured":"Van Schaik EA, Jacobson KA, Kim HO, IJzerman AP, and Danhof M (1996) Hemodynamic effects and histamine release elicited by the selective adenosine A3 receptor agonist 2-Cl-IB-MECA in conscious rats. Eur J Pharmacol 308: 311\u2013314.","DOI":"10.1016\/0014-2999(96)00373-1"},{"key":"10.1124\/jpet.107.127480_bib33","doi-asserted-by":"crossref","unstructured":"van Troostenburg AR, Clark EV, Carey WD, Warrington SJ, Kerns WD, Cohn I, Silverman MH, Bar-Yehuda S, Fong KL, and Fishman P (2004) Tolerability, pharmacokinetics and concentration-dependent hemodynamic effects of oral CF101, an A3 adenosine receptor agonist, in healthy young men. Int J Clin Pharmacol Ther 42: 534\u2013542.","DOI":"10.5414\/CPP42534"},{"key":"10.1124\/jpet.107.127480_bib34","unstructured":"Yang Z, Marshal M, Xu Y, French BA, and Linden J (2003) Opposing effects of the adenosine receptor agonist IB-MECA on myocardial infarct size in mice are mediated by A3 proinflammatory receptors and anti-inflammatory A2A receptors. Circulation 110: III-300."}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524342272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524342272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.107.127480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:29:25Z","timestamp":1740004165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524342272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0022356524342272"],"URL":"https:\/\/doi.org\/10.1124\/jpet.107.127480","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The A3 Adenosine Receptor Agonist CP-532,903 [N6-(2,5-Dichlorobenzyl)-3\u2032-aminoadenosine-5\u2032-N-methylcarboxamide] Protects against Myocardial Ischemia\/Reperfusion Injury via the Sarcolemmal ATP-Sensitive Potassium Channel","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.107.127480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2008 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}